Given that the Eya3 and PP2A-B55α interaction plays a major role in promoting breast tumor growth and metastasis (12, 21), inhibiting this interaction may serve as a potential therapeutic approach for breast and other Eya and Myc-driven cancers. Here, EYA3 is linked to breast neoplasm.